Bloodstream infections related to hemodialysis vascular access: microbiological patterns and clinical impact in a Brazilian dialysis service
DOI:
https://doi.org/10.66104/cfrm7t19Keywords:
Chronic kidney disease, Hemodialysis, Central venous catheters, Catheter-related infections, MicrobiologyAbstract
Chronic kidney disease shows a high prevalence in Brazil and worldwide, with substantial morbidity and mortality, and vascular access infection is the second leading cause of death among patients with chronic kidney disease. This retrospective study analyzed secondary medical record data from patients with positive blood cultures due to suspected vascular access infection between January 2021 and December 2024 in a hemodialysis service in the interior of Bahia, Brazil. Data were imported into Stata statistical software (Version 12.0). Categorical variables were described using absolute and relative frequencies, and continuous variables using measures of central tendency and dispersion. To assess associations between categorical variables, prevalence ratios and their respective 95% confidence intervals were calculated. A 5% significance level was adopted for all inferential analyses. The mean age of the cases was approximately 58 years (±16.6), with a predominance of male individuals (58.3%). Gram-positive microorganisms were more prevalent (68.7%), predominantly Staphylococcus aureus (48.7%), followed by Gram-negative microorganisms (31.3%), mainly Klebsiella spp. (12.2%). Patients with Staphylococcus aureus infection and those using a non-tunneled catheter had a higher prevalence of unfavorable clinical outcomes—death, hospitalization, and/or vascular access loss (58.1% and 82.1%, respectively). Gram-negative infection was associated with a more significant decrease in mean arterial pressure. In contrast, Gram-positive infection, especially Staphylococcus aureus infection, was associated with worse outcomes. These findings underscore the need for microbiological surveillance and targeted strategies for the prevention and management of vascular access-related infections, with potential impact on reducing unfavorable outcomes.Downloads
References
1. KGIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Nephrology and Dialysis, v. 19, n. 1, p. 22–206, 2017. DOI: https://doi.org/10.28996/1680-4422-2017-1-22-206
2. STEVENS, Paul E. et al. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International, v. 105, n. 4, p. S117–S314, abr. 2024. DOI: https://doi.org/10.1016/j.kint.2023.10.018
3. Francis, Anna, et al. “Chronic Kidney Disease and the Global Public Health Agenda: An International Consensus”. Nature Reviews Nephrology, v. 20, n. 7, julho de 2024, p. 473–85. DOI.org (Crossref), https://doi.org/10.1038/s41581-024-00820-6. DOI: https://doi.org/10.1038/s41581-024-00820-6
4. Cobo-Sánchez, José Luis, et al. “Early Identification of Local Infections in Central Venous Catheters for Hemodialysis: A Systematic Review”. Journal of Infection and Public Health, v. 16, n. 7, julho de 2023, p. 1023–32. DOI.org (Crossref), https://doi.org/10.1016/j.jiph.2023.04.012. DOI: https://doi.org/10.1016/j.jiph.2023.04.012
5. Nota Tecnica GVIMS/GGTES/DIRE3/ANVISA no 03/2024 - Critérios diagnósticos de IRAS — Agência Nacional de Vigilância Sanitária - Anvisa. https://www.gov.br/anvisa/pt-br/centraisdeconteudo/publicacoes/servicosdesaude/notas-tecnicas/2020/nota-tecnica-no-03-2024-criterios-diagnosticos-de-iras/view. Acesso em 3 de agosto de 2026.
6. Borg, Rikke, et al. “Chronic Kidney Disease in Primary Care: Risk of Cardiovascular Events, End Stage Kidney Disease and Death”. BMC Primary Care, v. 24, n. 1, junho de 2023, p. 128. DOI.org (Crossref), https://doi.org/10.1186/s12875-023-02077-7. DOI: https://doi.org/10.1186/s12875-023-02077-7
7. Miao, Peng, et al. “Mortality Outcomes Associated with Vascular Access Types in Hemodialysis for ESRD: A Systematic Review and Meta-Analysis”. BMC Nephrology, v. 27, n. 1, dezembro de 2025, p. 67. DOI.org (Crossref), https://doi.org/10.1186/s12882-025-04686-z. DOI: https://doi.org/10.1186/s12882-025-04686-z
8. Sohail, Mohammad Ahsan, et al. “Central Venous Catheters for Hemodialysis—the Myth and the Evidence”. Kidney International Reports, v. 6, n. 12, dezembro de 2021, p. 2958–68. DOI.org (Crossref), https://doi.org/10.1016/j.ekir.2021.09.009. DOI: https://doi.org/10.1016/j.ekir.2021.09.009
9. Nerbass, Fabiana B., et al. “Censo Brasileiro de Diálise 2023”. Brazilian Journal of Nephrology, v. 47, n. 1, março de 2025, p. e20240081. DOI.org (Crossref), https://doi.org/10.1590/2175-8239-jbn-2024-0081pt. DOI: https://doi.org/10.1590/2175-8239-jbn-2024-0081en
10. Lok, Charmaine E., et al. “Hemodialysis Vascular Access: Core Curriculum 2025”. American Journal of Kidney Diseases, v. 85, n. 2, fevereiro de 2025, p. 236–52. DOI.org (Crossref), https://doi.org/10.1053/j.ajkd.2024.05.021. DOI: https://doi.org/10.1053/j.ajkd.2024.05.021
11. Murt, Ahmet, et al. “Arteriovenous Fistula as the Vascular Access Contributes to Better Survival of Hemodialysis Patients with COVID-19 Infection”. The Journal of Vascular Access, v. 24, n. 1, janeiro de 2023, p. 22–26. DOI.org (Crossref), https://doi.org/10.1177/11297298211021253. DOI: https://doi.org/10.1177/11297298211021253
12. Erratum Regarding ‘KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update’ (Am J Kidney Dis. 2020;75[4][Suppl 2]:S1-S164)”. American Journal of Kidney Diseases, v. 77, n. 4, abril de 2021, p. 551. DOI.org (Crossref), https://doi.org/10.1053/j.ajkd.2021.02.002. DOI: https://doi.org/10.1053/j.ajkd.2021.02.002
13. Matos, Juliana Da Costa, et al. “Predictive factors of infection in patients with chronic kidney disease using hemodialysis catheters”. Jornal Vascular Brasileiro, v. 22, 2023, p. e20220098. DOI.org (Crossref), https://doi.org/10.1590/1677-5449.202200982. DOI: https://doi.org/10.1590/1677-5449.202200982
14. Venegas-Ramírez, Jesús, et al. “Vascular Access Type and Survival Outcomes in Hemodialysis Patients: A Seven-Year Cohort Study”. Medicina, v. 61, n. 4, março de 2025, p. 584. DOI.org (Crossref), https://doi.org/10.3390/medicina61040584. DOI: https://doi.org/10.3390/medicina61040584
15. Farrington, Crystal A., e Michael Allon. “Complications of Hemodialysis Catheter Bloodstream Infections: Impact of Infecting Organism”. American Journal of Nephrology, v. 50, n. 2, 2019, p. 126–32. DOI.org (Crossref), https://doi.org/10.1159/000501357. DOI: https://doi.org/10.1159/000501357
16. Li, Jiajing, et al. “Methicillin-Resistant Staphylococcus Aureus (MRSA): Resistance, Prevalence, and Coping Strategies”. Antibiotics, v. 14, n. 8, julho de 2025, p. 771. DOI.org (Crossref), https://doi.org/10.3390/antibiotics14080771. DOI: https://doi.org/10.3390/antibiotics14080771
17. Bai, Anthony D., et al. “Staphylococcus Aureus Bacteraemia Mortality: A Systematic Review and Meta-Analysis”. Clinical Microbiology and Infection, v. 28, n. 8, agosto de 2022, p. 1076–84. DOI.org (Crossref), https://doi.org/10.1016/j.cmi.2022.03.015. DOI: https://doi.org/10.1016/j.cmi.2022.03.015
18. Jesus-Silva, Seleno Glauber De, et al. “Análise das taxas de infecção e duração de cateteres de hemodiálise de curta e longa permanência em hospital de ensino”. Jornal Vascular Brasileiro, v. 19, 2020, p. e20190142. DOI.org (Crossref), https://doi.org/10.1590/1677-5449.190142. DOI: https://doi.org/10.1590/1677-5449.190142
19. Centers for Disease Control and Prevention (CDC). Dialysis Event Surveillance Form. Atlanta: CDC; [s.d.]. Available from: https://www.cdc.gov/nhsn/forms/57.502_dial_blank.pdf. Accessed 2026 Feb 2.
20. Rashid, Ishfaq, et al. “Malnutrition as a Potential Predictor of Mortality in Chronic Kidney Disease Patients on Dialysis: A Systematic Review and Meta-Analysis”. Clinical Nutrition, v. 43, n. 7, julho de 2024, p. 1760–69. DOI.org (Crossref), https://doi.org/10.1016/j.clnu.2024.05.037. DOI: https://doi.org/10.1016/j.clnu.2024.05.037
21. Minasyan, Hayk. “Sepsis: Mechanisms of Bacterial Injury to the Patient”. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, v. 27, n. 1, fevereiro de 2019, p. 19. Springer Link, https://doi.org/10.1186/s13049-019-0596-4. DOI: https://doi.org/10.1186/s13049-019-0596-4
Published
Issue
Section
License
Copyright (c) 2026 Anelise Costa dos Santos Botelho, Márcio Vasconcelos Oliveira, Samuel Luca Rocha Pinheiro, Mariana Santos Calmon, Marcel Silva Luz, Luis Guilherme de Oliveira Silva, Gabriel Reis Rocha , Gabriel Lima Correa Santos, Ana Cláudia Vaz do Amaral Barbosa Araújo, Fabricio Freire de Melo

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in this journal agree to the following terms:
Authors retain copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Creative Commons Attribution License, which permits the sharing of the work with proper acknowledgment of authorship and initial publication in this journal;
Authors are authorized to enter into separate, additional agreements for the non-exclusive distribution of the version of the work published in this journal (e.g., posting in an institutional repository or publishing it as a book chapter), provided that authorship and initial publication in this journal are properly acknowledged, and that the work is adapted to the template of the respective repository;
Authors are permitted and encouraged to post and distribute their work online (e.g., in institutional repositories or on their personal websites) at any point before or during the editorial process, as this may lead to productive exchanges and increase the impact and citation of the published work (see The Effect of Open Access);
Authors are responsible for correctly providing their personal information, including name, keywords, abstracts, and other relevant data, thereby defining how they wish to be cited. The journal’s editorial board is not responsible for any errors or inconsistencies in these records.
PRIVACY POLICY
The names and email addresses provided to this journal will be used exclusively for the purposes of this publication and will not be made available for any other purpose or to third parties.
Note: All content of the work is the sole responsibility of the author and the advisor.
